236 related articles for article (PubMed ID: 22816130)
1. Nanomedicines for delivery of therapeutic proteins and biopharmaceuticals.
Sarmento B
Ther Deliv; 2010 Aug; 1(2):231-5. PubMed ID: 22816130
[TBL] [Abstract][Full Text] [Related]
2. Inhalative nanomedicine--opportunities and challenges.
Bur M; Henning A; Hein S; Schneider M; Lehr CM
Inhal Toxicol; 2009 Jul; 21 Suppl 1():137-43. PubMed ID: 19558246
[TBL] [Abstract][Full Text] [Related]
3. Interview with John Patton.
Patton JS
Ther Deliv; 2010 Sep; 1(3):375-81. PubMed ID: 22816140
[No Abstract] [Full Text] [Related]
4. Polymer-based oral peptide nanomedicines.
Herrero EP; Alonso MJ; Csaba N
Ther Deliv; 2012 May; 3(5):657-68. PubMed ID: 22834409
[TBL] [Abstract][Full Text] [Related]
5. Drying technology strategies for colon-targeted oral delivery of biopharmaceuticals.
Vass P; Démuth B; Hirsch E; Nagy B; Andersen SK; Vigh T; Verreck G; Csontos I; Nagy ZK; Marosi G
J Control Release; 2019 Feb; 296():162-178. PubMed ID: 30677436
[TBL] [Abstract][Full Text] [Related]
6. Review: Nanopreparations for better drug delivery.
Qadir MI
Pak J Pharm Sci; 2017 Nov; 30(6):2301-2309. PubMed ID: 29175803
[TBL] [Abstract][Full Text] [Related]
7. Understanding molecular mechanisms of biologics drug delivery and stability from NMR spectroscopy.
Phyo P; Zhao X; Templeton AC; Xu W; Cheung JK; Su Y
Adv Drug Deliv Rev; 2021 Jul; 174():1-29. PubMed ID: 33609600
[TBL] [Abstract][Full Text] [Related]
8. New views and insights into intracellular trafficking of drug-delivery systems by fluorescence fluctuation spectroscopy.
Coppola S; Caracciolo G
Ther Deliv; 2014 Feb; 5(2):173-88. PubMed ID: 24483195
[TBL] [Abstract][Full Text] [Related]
9. Applications of carrier erythrocytes in delivery of biopharmaceuticals.
Hamidi M; Zarrin A; Foroozesh M; Mohammadi-Samani S
J Control Release; 2007 Apr; 118(2):145-60. PubMed ID: 17270305
[TBL] [Abstract][Full Text] [Related]
10. Safety profile of RNAi nanomedicines.
Barros SA; Gollob JA
Adv Drug Deliv Rev; 2012 Dec; 64(15):1730-7. PubMed ID: 22732527
[TBL] [Abstract][Full Text] [Related]
11. Lyophilization and nebulization of pulmonary surfactant-coated nanogels for siRNA inhalation therapy.
Merckx P; Lammens J; Nuytten G; Bogaert B; Guagliardo R; Maes T; Vervaet C; De Beer T; De Smedt SC; Raemdonck K
Eur J Pharm Biopharm; 2020 Dec; 157():191-199. PubMed ID: 33022391
[TBL] [Abstract][Full Text] [Related]
12. Interfering cancer with polymeric siRNA nanomedicines.
Tiram G; Scomparin A; Ofek P; Satchi-Fainaro R
J Biomed Nanotechnol; 2014 Jan; 10(1):50-66. PubMed ID: 24724498
[TBL] [Abstract][Full Text] [Related]
13. Availability of polymeric nanoparticles for specific enhanced and targeted drug delivery.
Kiriyama A; Iga K; Shibata N
Ther Deliv; 2013 Oct; 4(10):1261-78. PubMed ID: 24116911
[TBL] [Abstract][Full Text] [Related]
14. Delivery and targeting of nanoparticles into hair follicles.
Fang CL; Aljuffali IA; Li YC; Fang JY
Ther Deliv; 2014; 5(9):991-1006. PubMed ID: 25375342
[TBL] [Abstract][Full Text] [Related]
15. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
16. Drug delivery systems using polymer nanoassemblies for cancer treatment.
Bae Y
Ther Deliv; 2010 Sep; 1(3):361-3. PubMed ID: 22816139
[No Abstract] [Full Text] [Related]
17. Challenges for the pharmaceutical technical development of protein coformulations.
Mueller C; Altenburger U; Mohl S
J Pharm Pharmacol; 2018 May; 70(5):666-674. PubMed ID: 28470967
[TBL] [Abstract][Full Text] [Related]
18. Identification of Factors of Importance for Spray Drying of Small Interfering RNA-Loaded Lipidoid-Polymer Hybrid Nanoparticles for Inhalation.
Dormenval C; Lokras A; Cano-Garcia G; Wadhwa A; Thanki K; Rose F; Thakur A; Franzyk H; Foged C
Pharm Res; 2019 Aug; 36(10):142. PubMed ID: 31376020
[TBL] [Abstract][Full Text] [Related]
19. Lipid nanoparticles for the delivery of biopharmaceuticals.
Silva AC; Amaral MH; Lobo JM; Lopes CM
Curr Pharm Biotechnol; 2015; 16(4):291-302. PubMed ID: 25601601
[TBL] [Abstract][Full Text] [Related]
20. Nano drug-delivery systems in cancer therapy: gains, pitfalls and considerations in DMPK and PD.
Elbayoumi TA
Ther Deliv; 2010 Aug; 1(2):215-9. PubMed ID: 22816128
[No Abstract] [Full Text] [Related]
[Next] [New Search]
